V1512 - Treatment of Parkinson's Disease, No Country

 
Key Data:
Drug (brand/generic)
V1521
Company/licensee
Vernalis
Therapy class
Levodopa
Product description
Dopamine precursor
Current indication
Parkinson’s disease
Market sector
CNS
Development status
Phase III

Return to Project



Home
New On This Site
Products & Services
Company A-Z
Industry Projects
White Papers
Jobs & Careers
Press Releases
Events & Exhibitions
Newsletter
Advertise With Us
About Us
Client Area

For every phase of your drug development